Pharmacogenomic Testing to Guide Antidepressant Use Beneficial in Major Depression

Pharmacogenomic testing predicted to save the health system $956 million and bring health gains of 0.381 QALYs per patient.

Related Keywords

Vancouver ,British Columbia ,Canada ,United Kingdom ,Canadian ,British ,Shahzad Ghanbarian ,University Of British Columbia ,Canadian Medical Association ,Healthday News ,Canadian Medical ,